AAV9-GFAP-CDKN2A

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Animals1

Outcomes

3

Brain mass

no changein mice1

1 study
  1. AAV9-GFAP-CDKN2A has no effect on brain mass in mice.

    “At tissue collection, we did not observe significant effects of Cdkn2a over‐expression on brain mass”

    Animalsastrocytic over-expression in PS19 and NonTg miceanterior cortex and hippocampus4 months

    Increased Cdkn2a , a regulator of cellular senescence, in the PS19 mouse model of tauopathy

    AAIC 2025 abstract25 Dec 2025

Learning and memory

no changein mice1

1 study
  1. AAV9-GFAP-CDKN2A has no effect on learning and memory in mice.

    “Finally, we did not observe significant effects of Cdkn2a over‐expression on hippocampal dependent learning and memory as measured by the radial arm water maze.”

    Animalsastrocytic over-expression in PS19 and NonTg miceanterior cortex and hippocampus4 months

    Increased Cdkn2a , a regulator of cellular senescence, in the PS19 mouse model of tauopathy

    AAIC 2025 abstract25 Dec 2025

Pre-pulse inhibition of acoustic startle response

upin mice1

1 study
  1. AAV9-GFAP-CDKN2A improves pre-pulse inhibition of acoustic startle response in mice.

    “Surprisingly, we did observe a significant improvement in pre‐pulse inhibition of the acoustic startle response in PS19 mice over‐expressing Cdkn2a in astrocytes.”

    Animalsastrocytic over-expression in PS19 miceanterior cortex and hippocampus4 months

    Increased Cdkn2a , a regulator of cellular senescence, in the PS19 mouse model of tauopathy

    AAIC 2025 abstract25 Dec 2025

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months